Longevity Startup Geviti Raises $8.5m In Seed Round 

With its new funding, Geviti is targeting more equitable access to data-informed, longevity-focused healthcare

Geviti, a health tech startup focused on data- and AI-informed longevity care, has raised $8.5 million in seed funding, closing the round in less than a month.

The round drew participation from a diverse group of strategic investors, ranging from family offices to partners from the pharmaceutical and diagnostics industries, as well as prominent physicians and researchers.

The capital will be used to grow Geviti’s team, scale its digital health platform, advance its use of artificial intelligence and machine learning, and forge strategic partnerships with healthcare providers, research institutions, and wellness organizations.

“It’s incredible to live in a country where you can take an idea to better the world that stems from your own experience, prove you can build and execute it, and raise the resources to make it reality at scale,” Geviti founder and CEO Nathan Graville said.

Geviti’s main goal is to close the gap in access to longevity-focused care, a space historically dominated by high-cost models. The startup says it’s designing its platform with scalability and affordability in mind to deliver preventive healthcare to a wider population. 

Graville’s drive to reshape healthcare is deeply personal. In LinkedIn post, he shared that the idea for Geviti took root after losing his father to cancer at age 58, an experience that crystallized his belief that the healthcare system needed a fundamental shift.

While he acknowledges there is still a role for the often-criticized reactive model of healthcare, he argues that, for the first time, advancing tech and tools now exist to focus on proactive and preventative approaches.

“The mission we are on isn’t about replacing what works, it’s about pruning the bad and shifting our emphasis toward building a more complete system where prevention comes first, and no one has to get that call that came too late,” Graville wrote.

He began building Geviti in 2022 and is also developing additional health tech products currently in stealth.

“This $8.5 million will absolutely continue increasing our enterprise value and value to customers, but I believe the strategic value from this investor group can be worth far more than the capital itself,” Graville continued. “VCs are no doubt a huge part of America’s innovation engine, but that route isn’t always the best or only way forward in earlier rounds.”

The post Longevity Startup Geviti Raises $8.5M in Seed Round  appeared first on Athletech News.